This content is machine translated Prostate Cancer PSMA in diagnostics and therapy: Where is the journey leading? The prostate specific membrane antigen (PSMA) plays an increasingly important role not only in the diagnosis of prostate carcinoma. The radioligand 117Lutetium-PSMA-617also provides a new therapeutic option in advanced castration-resistant…
View Post 8 min This content is machine translated News in metastatic prostate cancer. What impact will the studies published in 2020/2021 have on clinical practice? The years 2020 and 2021 have brought some novelties in metastatic prostate cancer. Thus, with 177Lutetium-PSMA-617and the PARP inhibitor Olaparib, two new active substances are available. The latter is already… CME-Test
